Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127775531 | 12777553 | 1 | I | 20160628 | 20160924 | 20160924 | PER | US-TEVA-674856USA | TEVA | 0.00 | M | Y | 83.54000 | KG | 20160924 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127775531 | 12777553 | 1 | PS | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | 2 TABS TWICE A DAY AS NEEDED | 74569 | .125 | MG | TABLET | |||||||
| 127775531 | 12777553 | 2 | SS | CLONAZEPAM. | CLONAZEPAM | 1 | 74569 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127775531 | 12777553 | 1 | Essential tremor |
| 127775531 | 12777553 | 2 | Neuropathy peripheral |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127775531 | 12777553 | Dizziness | |
| 127775531 | 12777553 | Fatigue | |
| 127775531 | 12777553 | Gait disturbance | |
| 127775531 | 12777553 | Memory impairment | |
| 127775531 | 12777553 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127775531 | 12777553 | 1 | 20160614 | 0 |